Spruce Biosciences, Inc. (SPRBD)

Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.39	38.75	96.34	24.49	42.75	157.15
Short-Term Investments	-	-	-	54.59	46.22	-
Cash & Short-Term Investments	16.39	38.75	96.34	79.08	88.97	157.15
Cash Growth	-76.48%	-59.77%	21.83%	-11.12%	-43.39%	3904.84%
Prepaid Expenses	1.87	3.18	3.88	3.32	2.53	2.97
Restricted Cash	-	-	-	0.22	-	-
Other Current Assets	2.7	2.28	1.97	1	0.4	0.28
Total Current Assets	20.95	44.21	102.18	83.61	91.9	160.4
Property, Plant & Equipment	0.8	0.93	1.18	1.4	1.48	1.87
Long-Term Investments	-	-	-	-	32.46	-
Other Long-Term Assets	0.06	0.07	0.58	0.64	0.65	0.62
Total Assets	21.82	45.21	103.95	85.65	126.49	162.88
Accounts Payable	0.81	1.3	3.33	1.43	2.82	3.63
Accrued Expenses	5.88	12.05	14.35	9.26	5.69	3.33
Current Portion of Long-Term Debt	0.94	1.62	1.62	1.62	-	2.55
Current Portion of Leases	0.3	0.28	0.25	0.14	0.36	0.25
Current Unearned Revenue	-	-	4.91	-	-	-
Total Current Liabilities	8.06	15.25	24.47	12.45	8.87	9.76
Long-Term Debt	-	0.12	1.72	3.29	4.88	1.92
Long-Term Leases	0.58	0.74	1.02	1.26	1.29	1.65
Other Long-Term Liabilities	-	0.28	0.24	0.16	0.07	0.12
Total Liabilities	8.64	16.39	27.44	17.16	15.12	13.46
Common Stock	-	0	0	0	0	0
Additional Paid-In Capital	279.56	279.09	273.74	218.35	214.69	210.27
Retained Earnings	-266.38	-250.27	-197.23	-149.31	-103.13	-60.84
Comprehensive Income & Other	-	-	-	-0.56	-0.18	-
Total Common Equity	13.18	28.82	76.51	68.49	111.37	149.43
Shareholders' Equity	13.18	28.82	76.51	68.49	111.37	149.43
Total Liabilities & Equity	21.82	45.21	103.95	85.65	126.49	162.88
Total Debt	1.82	2.77	4.61	6.32	6.53	6.38
Net Cash (Debt)	14.56	35.99	91.73	72.76	82.44	150.77
Net Cash Growth	-77.93%	-60.77%	26.07%	-11.74%	-45.32%	-
Net Cash Per Share	25.54	65.41	178.65	231.95	264.66	1887.41
Filing Date Shares Outstanding	0.56	0.56	0.55	0.53	0.31	0.31
Total Common Shares Outstanding	0.56	0.56	0.55	0.31	0.31	0.31
Working Capital	12.89	28.96	77.72	71.16	83.02	150.63
Book Value Per Share	23.41	51.18	139.85	217.64	355.56	481.81
Tangible Book Value	13.18	28.82	76.51	68.49	111.37	149.43
Tangible Book Value Per Share	23.41	51.18	139.85	217.64	355.56	481.81
Machinery	-	-	-	-	-	0.06
Leasehold Improvements	-	-	-	-	-	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.